Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394).
Volume: 36, Issue: 15_suppl, Pages: 3531 - 3531
Published: May 20, 2018
Abstract
3531 Background: Complete cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) allow to prolong survival in patients with colorectal peritoneal metastases (CRPM), especially with a low tumor burden. The aim of the PROPHYLOCHIP multicentric randomized phase 3 study was to evaluate the potential survival benefit of a systematic second-look surgery plus HIPEC in patients at high risk of developing CRPM. Methods:...
Paper Details
Title
Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394).
Published Date
May 20, 2018
Journal
Volume
36
Issue
15_suppl
Pages
3531 - 3531
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History